Department of Pharmacology, Physiology and Therapeutics, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND 58203, USA.
Life Sci. 2012 Dec 10;91(23-24):1159-68. doi: 10.1016/j.lfs.2012.04.039. Epub 2012 May 11.
Elevated levels of circulating cholesterol are extrinsic factors contributing to the pathogenesis of sporadic Alzheimer's disease (AD). We showed previously that rabbits fed a cholesterol-enriched diet exhibited blood-brain barrier (BBB) dysfunction, increased accumulation of apolipoprotein B (ApoB) in brain neurons, and endolysosomes in brain had disturbed structures and functions. These effects were linked to increased amyloid beta (Aβ) production, increased tau-pathology, and disrupted synaptic integrity. Because pathological changes to endolysosomes represent a very early event in sporadic AD, we determined here the extent to which ApoB-containing LDL cholesterol altered the structure and function of endolysosomes and contributed to the development of AD-like pathology in primary cultured neurons.
Cholesterol distribution and endolysosome morphology were determined histologically. Endolysosome pH was measured ratio-metrically with LysoSensor dye. Endolysosome enzyme activity was measured for acid phosphatase, cathepsins B and D, and beta-site APP cleaving enzyme 1 (BACE-1). AD-like pathologies, including increased production of Aβ, increased tau-pathology, and disrupted synaptic integrity were determined using ELISA, immunoblotting, and immunostaining techniques.
Treatment of neurons with ApoB-containing LDL cholesterol increased endolysosome accumulation of cholesterol, enlarged endolysosomes, and elevated endolysosome pH. In addition, ApoB-containing LDL cholesterol increased endolysosome accumulation of BACE-1, enhanced BACE-1 activity, increased Aβ levels, increased levels of phosphorylated tau, and decreased levels of synaptophysin.
Our findings suggest strongly that alterations in the structure and function of endolysosomes play a key role in the exhibition of pathological features of AD that result from neuronal exposure to ApoB-containing LDL cholesterol.
循环胆固醇水平升高是导致散发性阿尔茨海默病(AD)发病的外在因素。我们之前的研究表明,喂食富含胆固醇的饮食的兔子表现出血脑屏障(BBB)功能障碍、载脂蛋白 B(ApoB)在脑神经元中的积累增加以及脑内内溶酶体结构和功能紊乱。这些影响与淀粉样β(Aβ)生成增加、tau 病理学增加和突触完整性破坏有关。由于内溶酶体的病理变化代表散发性 AD 的一个非常早期的事件,因此我们在这里确定载脂蛋白 B 含量的 LDL 胆固醇改变内溶酶体的结构和功能的程度,并有助于原代培养神经元中 AD 样病理学的发展。
通过组织学方法确定胆固醇的分布和内溶酶体的形态。用 LysoSensor 染料比色法测量内溶酶体 pH 值。用酸性磷酸酶、组织蛋白酶 B 和 D 以及β位 APP 切割酶 1(BACE-1)对内溶酶体酶活性进行测量。采用 ELISA、免疫印迹和免疫染色技术测定 AD 样病变,包括 Aβ生成增加、tau 病理学增加和突触完整性破坏。
用载脂蛋白 B 含量的 LDL 胆固醇处理神经元会增加内溶酶体胆固醇的积累,使内溶酶体增大,并升高内溶酶体 pH 值。此外,载脂蛋白 B 含量的 LDL 胆固醇增加了内溶酶体中 BACE-1 的积累,增强了 BACE-1 的活性,增加了 Aβ水平,增加了磷酸化 tau 的水平,降低了突触小泡蛋白的水平。
我们的研究结果强烈表明,内溶酶体结构和功能的改变在神经元暴露于载脂蛋白 B 含量的 LDL 胆固醇导致的 AD 病理特征的表现中起着关键作用。